News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
443,812 Results
Type
Article (18167)
Company Profile (122)
Press Release (425515)
Multimedia
Podcasts (77)
Webinars (14)
Section
Business (141641)
Career Advice (854)
Deals (25703)
Drug Delivery (86)
Drug Development (49050)
Employer Resources (69)
FDA (8983)
Job Trends (9104)
News (229597)
Policy (19317)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (802)
Accelerated approval (26)
Adcomms (12)
Allergies (100)
Alliances (33891)
ALS (102)
Alzheimer's disease (838)
Antibody-drug conjugate (ADC) (205)
Approvals (9333)
Artificial intelligence (363)
Autoimmune disease (138)
Automation (27)
Bankruptcy (218)
Best Places to Work (6542)
BIOSECURE Act (10)
Biosimilars (155)
Biotechnology (57)
Bladder cancer (90)
Brain cancer (46)
Breast cancer (328)
Cancer (2620)
Cardiovascular disease (252)
Career advice (751)
Career pathing (17)
CAR-T (115)
CDC (11)
Celiac Disease (1)
Cell therapy (350)
Cervical cancer (22)
Clinical research (43079)
Collaboration (1243)
Company closure (1)
Compensation (725)
Complete response letters (47)
COVID-19 (1153)
CRISPR (69)
C-suite (845)
Cystic fibrosis (81)
Data (3784)
Decentralized trials (2)
Denatured (24)
Depression (82)
Dermatology (36)
Diabetes (240)
Diagnostics (3435)
Digital health (21)
Diversity (4)
Diversity, equity & inclusion (20)
Drug discovery (182)
Drug pricing (128)
Drug shortages (16)
Duchenne muscular dystrophy (132)
Earnings (63868)
Editorial (26)
Employer branding (9)
Employer resources (67)
Events (70005)
Executive appointments (841)
FDA (10886)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (10)
Frontotemporal dementia (15)
Funding (873)
Gene editing (109)
Generative AI (28)
Gene therapy (324)
GLP-1 (588)
Government (1829)
Grass and pollen (4)
Guidances (283)
Healthcare (8388)
HIV (29)
Huntington's disease (16)
IgA nephropathy (57)
Immunology and inflammation (124)
Immuno-oncology (36)
Indications (114)
Infectious disease (1280)
Inflammatory bowel disease (110)
Inflation Reduction Act (7)
Influenza (44)
Intellectual property (156)
Interviews (106)
IPO (11599)
IRA (33)
Job creations (2793)
Job search strategy (667)
JPM (31)
Kidney cancer (15)
Labor market (37)
Layoffs (278)
Leadership (17)
Legal (5252)
Liver cancer (44)
Longevity (14)
Lung cancer (324)
Lymphoma (213)
Machine learning (23)
Management (25)
Manufacturing (648)
MASH (125)
Medical device (5338)
Medtech (5381)
Mergers & acquisitions (14915)
Metabolic disorders (738)
mRNA (79)
Multiple sclerosis (72)
NASH (18)
Neurodegenerative disease (155)
Neuropsychiatric disorders (58)
Neuroscience (1561)
Neurotech (1)
NextGen: Class of 2026 (3027)
Non-profit (1536)
Now hiring (27)
Obesity (348)
Opinion (172)
Ovarian cancer (88)
Pain (159)
Pancreatic cancer (130)
Parkinson's disease (146)
Partnered (20)
Patents (312)
Patient recruitment (257)
Peanut (19)
People (43915)
Pharmaceutical (64)
Pharmacy benefit managers (18)
Phase 1 (11997)
Phase 2 (18659)
Phase 3 (15556)
Pipeline (5373)
Policy (167)
Postmarket research (1715)
Preclinical (4860)
Press Release (72)
Prostate cancer (146)
Psychedelics (24)
Radiopharmaceuticals (216)
Rare diseases (602)
Real estate (3963)
Recruiting (26)
Regulatory (14963)
Reports (25)
Research institute (895)
Resumes & cover letters (118)
Rett syndrome (33)
RNA editing (15)
RSV (28)
Schizophrenia (122)
Series A (151)
Series B (108)
Service/supplier (4)
Sickle cell disease (62)
Special edition (12)
Spinal muscular atrophy (99)
Sponsored (19)
Startups (2272)
State (2)
Stomach cancer (7)
Supply chain (67)
Tariffs (72)
The Weekly (51)
Vaccines (384)
Venture capital (49)
Weight loss (193)
Women's health (55)
Worklife (6)
Date
Last 7 days (362)
Last 30 days (1879)
Last 365 days (16983)
2026 (7385)
2025 (17374)
2024 (20416)
2023 (23804)
2022 (32353)
2021 (34281)
2020 (32060)
2019 (25111)
2018 (19323)
2017 (20346)
2016 (19300)
2015 (23398)
2014 (19126)
2013 (16089)
2012 (17362)
2011 (18042)
2010 (17068)
Location
Africa (463)
Alabama (37)
Alaska (3)
Arizona (140)
Arkansas (5)
Asia (28293)
Australia (3768)
California (6850)
Canada (2880)
China (831)
Colorado (325)
Connecticut (314)
Delaware (216)
Europe (57784)
Florida (1218)
Georgia (159)
Hawaii (1)
Idaho (31)
Illinois (582)
India (77)
Indiana (395)
Iowa (13)
Japan (415)
Kansas (98)
Kentucky (33)
Louisiana (17)
Maine (59)
Maryland (730)
Massachusetts (5375)
Michigan (200)
Minnesota (385)
Mississippi (3)
Missouri (69)
Montana (19)
Nebraska (17)
Nevada (74)
New Hampshire (35)
New Jersey (2396)
New Mexico (14)
New York (1910)
North Carolina (1070)
North Dakota (6)
Northern California (3456)
Ohio (209)
Oklahoma (11)
Oregon (25)
Pennsylvania (1512)
Puerto Rico (18)
Rhode Island (26)
South America (696)
South Carolina (27)
South Dakota (1)
Southern California (2752)
Tennessee (137)
Texas (1108)
United States (26048)
Utah (174)
Virginia (254)
Washington D.C. (47)
Washington State (578)
West Virginia (3)
Wisconsin (103)
Wyoming (2)
443,812 Results for "alliance pharmaceutical corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Zenith Capital Corp. Amends Promissory Notes
May 12, 2026
·
6 min read
Press Releases
GSK and the pan-Canadian Pharmaceutical Alliance (pCPA) initiate negotiations for Blenrep for the treatment of relapsed or refractory multiple myeloma
May 20, 2026
·
3 min read
Press Releases
Illumisoft Lighting Corp. Provides Corporate Update Following Commencement of Trading
May 5, 2026
·
14 min read
Press Releases
LIR Life Sciences Corp. Announces Agreement with Resilience BioSciences Inc.
April 21, 2026
·
5 min read
Press Releases
Resverlogix Corp. Announces Issuance of MCTO by ASC
April 2, 2026
·
4 min read
Business
Lilly exits Rigel alliance, adding to RIPK1 scrap heap
Eli Lilly and Rigel Pharmaceuticals partnered in February 2021 to advance a pair of RIPK1 blockers, but the pharma in October last year pulled the plug on one of these programs for central nervous system indications.
April 22, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Resverlogix Corp. Announces Filing of Annual Filings and Revocation of MCTO
April 16, 2026
·
2 min read
Press Releases
Scryb Inc. Changes Name to NorthPalm Capital Corp. and Announces New Trading Symbols
May 5, 2026
·
2 min read
Press Releases
Conavi Medical Corp. Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants
May 11, 2026
·
6 min read
Press Releases
BioNexus Gene Lab Corp. (Nasdaq: BGLC) and Fidelion Diagnostics Execute Exclusive Southeast Asia License for VitaGuard™ MRD Platform as Part of Strategic Alliance with Tongshu Gene
December 2, 2025
·
8 min read
1 of 44,382
Next
